The sphere of thoracic and cardiothoracic surgical procedure is expanding fast, driven by breakthrough developments in robotic-assisted surgeries, minimally invasive lung cancer interventions, and revolutionary cardiac valve therapies. For B2B corporations—ranging from specialized surgical instrumen